Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (5)
  • 2025 (6)

Subject

  • Drug Trafficking (140)
  • OCDETF/Task Force (22)
  • Fentanyl Free America (14)
  • Guns/Weapons (13)
  • Diversion Division (10)
  • Money Laundering (10)
  • Take Back Day (9)
  • Fentanyl Awareness (8)
  • Guilty Plea (8)
  • Synthetic drugs (8)
  • Arrests/Convictions - Major (7)
  • Outreach/Drug Prevention (7)
  • Major Law Enforcement Operation (6)
  • Pharmaceuticals/Pharmacists/Physicians (6)
  • Fake Pills (5)
  • One Pill Can Kill (5)
  • Campaigns (3)
  • Cartel (3)
  • Counterfeit Pills (3)
  • Extraditions (3)
  • Other (3)
  • Press Conferences (3)
  • Public and Media Affairs - also see Congressional Affairs (3)
  • Seizures (Drugs/Property) (3)
  • Terrorism (3)
  • Gangs (2)
  • International/Foreign Operations (2)
  • Narcoterrorism (2)
  • Overdose (2)
  • Prevention/Education - DEA websites GSAD, JTT etc (2)
  • Task Forces/Task Force Officers (2)
  • Critical Incident (1)
  • Intelligence Division - Intelligence Products (1)
  • Intergovernmental Affairs (1)
  • Museum and Visitors Center (1)
  • Red Ribbon (1)
  • Prescription Drugs (11)

Drug Name

  • Oxycodone (2)
  • Cocaine (1)
  • Fentanyl (1)
  • Heroin (1)
  • Marijuana (Cannabis) (1)
  • Marijuana Concentrates (1)
  • Methamphetamine (1)
  • Opioids (1)

Field Division

  • Atlanta (3)
  • Caribe (1)
  • Dallas (1)
  • Detroit (1)
  • El Paso (6)
  • Los Angeles (4)
  • Louisville (13)
  • Miami (7)
  • New England (6)
  • New Jersey (2)
  • New Orleans (3)
  • New York (7)
  • Omaha (7)
  • Phoenix (4)
  • Rocky Mountain (3)
  • San Diego (1)
  • San Francisco (9)
  • Seattle (10)
  • Sede (8)
  • St. Louis (5)
  • Tampa (2)
  • Washington, DC (4)
Clear All Results
View Archived Press Releases
11 Results - Showing 1 to 10
PRESS RELEASE

Walmart Agrees to Pay $50 Million for Illegally Filling Unlawful Opioid Prescriptions

Washington, D.C. — The Justice Department, together with the Drug Enforcement Administration (DEA), today announced a $50 million settlement with Walmart Inc. (Walmart) to resolve allegations that Walmart pharmacies illegally filled thousands of invalid prescriptions for opioids and other controlled substances in violation of the Controlled Substances Act (CSA). “This...
PRESS RELEASE

North Carolina Physician Sentenced to Prison

CHARLOTTE, N.C. – A North Carolina physician has been sentenced to prison for conspiring to allow his Drug Enforcement Administration (DEA) registration number to be used for thousands of unlawful buprenorphine prescriptions, announced Russ Ferguson, U.S. Attorney for the Western District of North Carolina. U.S. District Judge Kenneth D. Bell...
PRESS RELEASE

Founder/CEO and Clinical President of Digital Health Company Sentenced for $90 Million Scheme to Distribute over 37 Million Pills of Adderall

Washington, D.C - The founder and former Chief Executive Officer (CEO) Ruthia He of Done Global Inc., a California-based digital mental health company, was sentenced today to six years in prison and a fine of $1 million for orchestrating a scheme that used her company’s technology platform, compensation structure, and...
PRESS RELEASE

Texas Doctor Convicted for Illegally Distributing More than a Million Pills

WASHINGTON D.C. - A federal jury in the Southern District of Texas convicted a Texas physician yesterday for unlawfully distributing more than a million pills of opioids and other dangerous controlled substances. “Medical physicians who exploit their prescribing authority for profit over patient care break an inherent trust with their...
PRESS RELEASE

DEA Releases 2026 Aggregate Production Quotas

WASHINGTON – This week the U.S. Drug Enforcement Administration released the established aggregate production quotas (APQ) for schedule I and II controlled substances and assessment of annual needs (AAN) for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine for 2026. “DEA is committed to ensuring that patients can access the...
PRESS RELEASE

DEA Extends Telemedicine Flexibilities to Ensure Continued Access to Care

WASHINGTON – The U.S. Drug Enforcement Administration, in partnership with the Department of Health and Human Services (HHS), has issued a Fourth Temporary Extension of the COVID-19 Telemedicine Flexibilities for the Prescription of Controlled Medications , extending the current telemedicine flexibilities through December 31, 2026. Under these telemedicine flexibilities, DEA-registered...
PRESS RELEASE

DEA Hosts the 29th National Prescription Drug Take Back Day on Saturday, October 25th

WASHINGTON –The Drug Enforcement Administration, in collaboration with nearly 4,000 law enforcement partners across the country, will host the 29th National Prescription Drug Take Back Day this Saturday, October 25, from 10 a.m. to 2 p.m. At nearly 4,000 collection sites throughout the United States, DEA’s National Prescription Drug Take...
PRESS RELEASE

DEA Hosts the 29th National Prescription Drug Take Back Day on Saturday, October 25th

WASHINGTON –The Drug Enforcement Administration, in collaboration with nearly 4,000 law enforcement partners across the country, will host the 29th National Prescription Drug Take Back Day this Saturday, October 25, from 10 a.m. to 2 p.m. At nearly 4,000 collection sites throughout the United States, DEA’s National Prescription Drug Take...
PRESS RELEASE

Gastonia Pharmacist Sentenced to Prison for Illegal Distribution of Oxycodone

CHARLOTTE, N.C. – Cole Dixon Moore, 36, of Moore, South Carolina, was sentenced yesterday to two years in prison for illegally distributing oxycodone pills, announced Russ Ferguson, U.S. Attorney for the Western District of North Carolina. Jae W. Chung, Acting Special Agent in Charge of the Atlanta Field Division of...
PRESS RELEASE

DEA Releases 2025 National Drug Threat Assessment

WASHINGTON – The U.S. Drug Enforcement Administration today announced the release of the 2025 National Drug Threat Assessment (NDTA), DEA’s comprehensive review of the threats posed to the United States by deadly illicit drugs and the violent domestic and international drug trafficking organizations responsible for producing and trafficking the drugs...

Paginación

  • Current page 1
  • Page 2
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster